GSK Investigational Site
Erlangen 91054
1 studies enrolling now · 3 studies all time
What they study most
Cholestasis, Neoplasms, Breast, Neoplasms, Head and Neck
Studies at this site
- A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma — Recruiting now
- Linerixibat Long-term Safety, and Tolerability Study — Running, not enrolling
- Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease — Running, not enrolling